Do Laboratory Prescribed and Ad Libitum Use Sessions Represent Real-World ENDS Use?

SOL #: 75F40125R00096Combined Synopsis/Solicitation

Overview

Buyer

Health And Human Services
Food And Drug Administration
FOOD AND DRUG ADMINISTRATION
ROCKVILLE, MD, 20857, United States

Place of Performance

Rockville, MD

NAICS

Testing Laboratories and Services (541380)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
Jul 28, 2025
2
Submission Deadline
Aug 25, 2025, 6:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

See Attached Combined Synopsis/Solicitation for 75F40125R00096.

People

Points of Contact

Janice HeardPRIMARY
Janice.Heard@fda.hhs.gov
215-717-3093
Madeline BryantSECONDARY
Madeline.Bryant@fda.hhs.gov
240-402-7611

Files

Files

Download

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Jul 28, 2025
Do Laboratory Prescribed and Ad Libitum Use Sessions Represent Real-World ENDS Use? | GovScope